Patent Application
Utility
App. No. 17/903,507
· Confirmation No. 1095
COMBINATION THERAPY FOR CANCER TREATMENT
Applicant:
Takeda Pharmaceutical Company Limited
Abandoned -- Incomplete Application (Pre-examination)
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2023-06-21 | ABN |
Abandonment | 2 | View | |
| 2023-04-26 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2023-04-26 | NT.INC.REPLY |
Notice of Incomplete Reply | 4 | View | |
| 2023-03-16 | LET. |
Miscellaneous Incoming Letter | — | View | |
| 2023-03-16 | TRAN.LET |
Transmittal Letter | 1 | View | |
| 2023-03-16 | TRAN.LET |
Transmittal Letter | 1 | View | |
| 2023-03-16 | XT/ |
Extension of Time | 1 | View | |
| 2023-03-16 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2023-03-16 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2022-10-18 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2022-10-18 | SEQ.REQ.DISC |
Requirements for Sequence Disclosure Notice | 5 | View | |
| 2022-10-18 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2022-09-29 | CRFD |
Sequence Listing in Computer Readable Format is Defective | 12 | View | |
| 2022-09-29 | CRFD |
Sequence Listing in Computer Readable Format is Defective | — | View | |
| 2022-09-06 | TRAN.LET |
Transmittal Letter | 1 | View | |
| 2022-09-06 | SPEC |
Specification | 20 | View | |
| 2022-09-06 | CLM |
Claims | 4 | View | |
| 2022-09-06 | ABST |
Abstract | 1 | View | |
| 2022-09-06 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2022-09-06 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2022-09-06 | TRNA |
Transmittal of New Application | 2 | View | |
| 2022-09-06 | ADS |
Application Data Sheet | 8 | View | |
| 2022-09-06 | OATH |
Oath or Declaration filed | 2 | View | |
| 2022-09-06 | CRFS |
CRF Statement that Sequence Listing text file (CRF) and paper/pdf Sequence Listing are the same | 1 | View | |
| 2022-09-06 | A.PE |
Preliminary Amendment | 1 | View | |
| 2022-09-06 | SPEC |
Specification | 1 | View | |
| 2022-09-06 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2022-09-06 | SEQ.TXT |
Sequence Listing (Text File) | 1 | View |
Inventors
Richard Labotka
Des Plaines, IL
Andrew Fergus
Andover, MA
Attorneys & Agents of Record
Prosecution
- Customer No.
- 114119
- Docket No.
- 223266/15-004USCN4/516528
- Confirmation No.
- 1095
Parent
is a Continuation of
→
App. 17/680,718
Filed 2022-02-25
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 17/392,158
Filed 2021-08-02
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 17/154,498
Filed 2021-01-21
· Abandoned -- Incomplete Application (Pre-examination)
Parent
is a Continuation of
→
App. 15/551,093
Filed 2017-08-15
· Abandoned -- Failure to Respond to an Office Action
Parent
PCT
is a National Stage Entry of
→
PCT/US2016/018070
Filed 2016-02-16
· Abandoned -- Incomplete Application (Pre-examination)
Parent
Claims priority from a provisional application
→
App. 62/117,283
Filed 2015-02-17
· Provisional Application Expired
Child
is a Continuation of
→
App. 18/184,918
Filed 2023-03-16
· Abandoned -- Incomplete Application (Pre-examination)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2022-11-10
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 17/903,507
- Filed
- 2022-09-06
External Links